Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Children's Health

Font Size

Gene Therapy May Help Muscular Dystrophy Patients

Research May Lead to Future Treatments for Duchenne Muscular Dystrophy
WebMD Health News
Reviewed by Laura J. Martin, MD

July 25, 2011 -- Scientists say they have successfully tested a new treatment that may one day help children with a severe form of muscular dystrophy.

Duchenne muscular dystrophy is caused by the absence of a protein that helps keep muscle cells intact. It affects about one in every 3,500 newborns and causes progressive muscle weakness and early death.

Children with the disease, who are usually boys, typically lose the ability to walk by age 12 and often die before age 25, usually from heart and lung problems.

Treatments aim to slow the gradual decline and manage symptoms. There's no cure.

Fixing a Flawed Gene

The new therapy uses a clever bit of genetic sleight-of-hand to repair an inherited defect in the blueprints the body uses to make the muscle protein dystrophin.

The treatment uses artificially created nucleotides, the building blocks of DNA and RNA, to mask the defect, helping cells to skip over the flawed part of the protein's instructions.

The end result is a shortened but functional protein.

To understand what the treatment does, Andrian R. Krainer, PhD, a professor molecular genetics at Cold Spring Harbor Laboratory in New York, says it helps to think of the protein as a long spring.

"If it's missing one of the ends, it cannot be anchored at both ends. But if it's missing some coils in the middle, it can still work reasonably well," says Krainer, who is testing this approach to treat a different disease, but was not involved in the research.

The treatment isn't a cure, but it may help people live longer with less disability.

"You're essentially converting a very severe patient to a Becker patient," says study researcher Ryszard Kole, PhD. Becker muscular dystrophy is a milder form of the disease.

Kole developed the theory behind the treatment while a professor of pharmacology at the University of North Carolina at Chapel Hill. He is now a senior vice president at AVI BioPharma, the company that's developing the treatment.

First Human Tests

The study, which is published in The Lancet, tested increasing doses of the artificial nucleotides in 19 Duchenne patients, who ranged in age from 5 to 15.

Today on WebMD

child with red rash on cheeks
What’s that rash?
plate of fruit and veggies
How healthy is your child’s diet?
smiling baby
Treating diarrhea, fever and more.
Middle school band practice
Understanding your child’s changing body.

worried kid
jennifer aniston
Measles virus
sick child

Child with adhd
rl with friends
Syringes and graph illustration